Effect of antioxidants on functional recovery after in vitro-induced ischemia and long-term potentiation recorded in the pyramidal layer of the CA1 area of rat hippocampus

General Physiology and Biophysics

Volumn 33, Issue 1, 2014, Pages 43-52

  Gasparova, Zdenka ^a   Stara, Veronika ^a   Stolc, Svorad ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Antioxidants; Hippocampus; Ischemia; Long term potentiation; Rat

Indexed keywords

ANIMALS; ANOXIA; ANTIOXIDANTS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CARBOLINES; COGNITION; ELECTROPHYSIOLOGY; HYPOGLYCEMIA; ISCHEMIA; LONG-TERM POTENTIATION; MALE; OXIDATIVE STRESS; OXYGEN; PYRAMIDAL CELLS; RATS; TIME FACTORS;

EID: 84894203947     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2013062     Document Type: Article

References (59)

1. Barkov N. K. (1973): On the mechanism of action of carbidine. Pharmacol. Toxicol. 36, 154-157
2. Benes L., Stolc S. (1989): Stobadine. Drugs Future 14, 135-137
3. Bliss T. V., Collingridge G. L. (1993): A synaptic model of memory: Longterm potentiation in the hippocampus. Nature 361, 31-39 http://dx.doi.org/ 10.1038/361031a0
4. Brouns R., De Deyn P. P. (2009): The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111, 483-495 http://dx.doi.org/10.1016/j.clineuro.2009.04.001
5. Candelario-Jalil E. (2009): Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr. Opin. Investig. Drugs. 10, 644-654
6. Canhao P., de Mendonca A., Ribeiro J. A. (1994): 1,3-Dipropyl-8- cyclopentylxantine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res. 661, 265-273 http://dx.doi.org/10.1016/0006-8993(94) 91203-3
7. Cao X. J., Wang M., Chen W. H., Zhu D. M., She J. Q., Ruan D. Y. (2009): Effects of chronic administration of melatonin on spatial learning ability and long-term potentiation in leadexposed and control rats. Biomed. Environ. Sci. 22, 70-75 http://dx.doi.org/10.1016/S0895-3988(09)60025-8
8. Cumming T. B., Marshall R. S., Lazar R. M. (2013): Stroke, cognitive deficits and rehabilitation: still an incomplete picture. Int. J. Stroke 8, 38-45 http://dx.doi.org/10.1111/j.1747-4949.2012.00972.x
9. Chan P. H. (2001): ROS in signaling and damage in the ischemic brain. Cereb. Blood Flow Metab. 21, 2-14 http://dx.doi.org/10.1097/00004647-200101000- 00002
10. Collingridge G. I., Kehl S. J., McClennan H. (1983): Ecxitatory amino acids in synaptic transmission in the Schäffer collateral-commissural pathway of the rat hippocampus. J. Physiol. (London) 334, 33-46
11. Fatokun A. A., Stone T. W., Smith R. A. (2008): Oxidative stress in neurodegeneration and available means of protection. Front. Biosci. 13, 3288-3311 http://dx.doi.org/10.2741/2926
12. Gasparova Z., Stolc S., Snirc V. (2006): In vitro physiological evidence of enhanced neuroprotective and antioxidant action of 2,3-dihydromelatonin: a melatonin analogue. Pharmacol. Res. 53, 22-27 http://dx.doi.org/10.1016/j.phrs. 2005.08.004
13. Gasparova Z., Jariabka P., Stolc S. (2008): Effect of transient ischemia on long-term potentiation of synaptic transmission in rat hippocampal slices. Neuroendocrinol. Lett. 29, 702-705
14. Gasparova Z., Ondrejickova O., Gajdosikova A., Gajdosik A., Snirc V., Stolc S. (2010): Oxidative stress induced by the Fe2+/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue. Interdisc. Toxicol. 3, 122-126 http://dx.doi.org/10.2478/v10102-010-0051-x
15. Gasparova Z., Snirc V., Stolc S. (2011): The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia- induced impairment of long-term potentiation in rat hippocampus. Interdisc. Toxicol. 4, 56-61 http://dx.doi.org/10.2478/v10102-011-0011-0
16. Gahtan E., Auerbach J. M., Groner Y., Segal M. (1998): Reversible impairment of long-term potentiation in transgenic Cu/Zn- SOD mice. Eur. J. Neurosci. 10, 538-544 http://dx.doi.org/10.1046/j.1460-9568.1998.00058.x
17. Hall E. D., Braughler J. M., McCall J. M. (1992): Antioxidant effects in brain and spinal cord injury. J. Neurotrauma 9, S165-172
18. Hall E. D., Andrus P. K., Smith S. L., Oostveen J. A., Scherch H. M., Lutzke B. S., Raub T. J., Sawada G.A., Palmer J.R., Banitt L.S., Tustin J.S., Belonga K.L., Ayer D.E., Bundy G. L. (1996): Neuroprotective efficacy of microvascularly-localized versus brainpenetrating antioxidants. Acta Neurochir. 66, S107-113
19. Hofmeijer J., van Putten M. J. A. M. (2012): Ischemic cerebral damage an appraisal of synaptic failure. Stroke 43, 607-615 http://dx.doi.org/10.1161/ STROKEAHA.111.632943
20. Horakova L., Stolc S. (1998): Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol. 30, 627-638 http://dx.doi.org/10.1016/ S0306-3623(97)00300-5
21. Jackson T. C., Rani A., Kumar A., Foster T. C. (2009): Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging. Cell Death Differ. 16, 439-448 http://dx.doi.org/10.1038/cdd.2008.171
22. Juranek I., Horakova L., Rackova L., Stefek M. (2010): Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr. Med. Chem.17, 552-570 http://dx.doi.org/10.2174/092986710790416317
23. Juranek I., Rackova L., Stefek M. (2012): Stobadine - an indole type alternative to the phenolic antioxidant reference trolox. In: Biochemistry. (Ed. D. Ekinci), pp. 443-452, InTech, Rijeka http://dx.doi.org/10.5772/32784
24. Klann E. (1998): Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J. Neurophysiol. 80, 452-457
25. Klann E., Robertson E. D., Knapp L. T., Sweatt J. D. (1998): A role for superoxide in protein kinase C activation and induction of long-term potentiation. J. Biol. Chem. 273, 4516-4522 http://dx.doi.org/10.1074/jbc.273.8. 4516
26. Knapp L. T., Klann E. (2002a): Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J. Neurosci. 22, 674-683
27. Knapp L. T., Klann E. (2002b): Role of reactive oxygen species in hippocampal long-term potentiation: Contributory or inhibitory? J. Neurosci. Res. 70, 1-7 http://dx.doi.org/10.1002/jnr.10371
28. Larsson E., Lindvall O., Kokaia Z. (2001): Stereological assessment of vulnerability of immunocytochemically identified striatal and hippocampal neurons after global cerebral ischemia in rats. Brain Res. 913, 117-132 http://dx.doi.org/10.1016/S0006-8993(01)02762-7
29. Latini S., Bordoni F., Corradetti R., Pepeu G., Pedata F. (1999): Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol. 128, 1035-1044 http://dx.doi.org/10.1038/sj.bjp.0702888
30. Lynch G., Larson K., Kelso S., Barrionuevo G., Schottler F. (1983): Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 305, 719-721 http://dx.doi.org/10.1038/305719a0
31. Lynch M. A. (1998): Analysis of the mechanisms underlying the age-related impairment in long-term potentiation in the rat. Rev. Neurosci. 9, 169-201 http://dx.doi.org/10.1515/REVNEURO.1998.9.3.169
32. Lynch M. A. (2004): Long-term potentiation and memory. Physiol. Rev. 84, 87-136 http://dx.doi.org/10.1152/physrev.00014.2003
33. Malenka R. C., Kauer J. A., Zucker R. S., Nicoll R. A. (1988): Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242, 81-84 http://dx.doi.org/10.1126/science.2845577
34. Malenka R. C., Nicoll R. A. (1999): Long-term potentiation: a decade of progress? Science 285, 1870-1874 http://dx.doi.org/10.1126/science.285.5435.1870
35. McGahon B. M., Martin D. S., Horrobin D. F., Lynch M. A. (1999a): Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94, 305-314 http://dx.doi.org/10.1016/S0306-4522(99)00219-5
36. McGahon B. M., Martin D. S., Horrobin D. F., Lynch M. A. (1999b): Age-related changes in LTP and antioxidant defenses are reversed by α-lipoic acid-enriched diet. Neurobiol. Aging 20, 655-664 http://dx.doi.org/10.1016/S0197-4580(99)00050-0
37. Morris R. G. M. (2003): Long-term potentiation and memory. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358, 643-647 http://dx.doi.org/10.1098/rstb.2002. 1230
38. Murray C. A., Lynch M. A. (1998): Dietary supplementation with vitamin E reverses the age-related deficits in long-term potentiation in dentate gyrus. J. Biol. Chem. 273, 12161-12168 http://dx.doi.org/10.1074/jbc.273.20.12161
39. Negishi H., Ikeda K., Nara Y., Yamori Y. (2001): Increased hydroxyl radicals in the hippocampus of stroke-prone spontaneously hypertensive rats during transient ischemia and recirculation. Neurosci. Lett. 306, 206-208 http://dx.doi.org/10.1016/S0304-3940(01)01893-6
40. O'Donnell E., Lynch M. A. (1998): Dietary antioxidant supplementation reverses age-related neuronal changes. Neurobiol. Aging 19, 461-467 http://dx.doi.org/10.1016/S0197-4580(98)00082-7
41. Olney J.W. (1994): New mechanisms of excitatory transmitter neurotoxicity. J. Neural. Transm. Suppl. 43, 47-51
42. Pellmar T. C., Roney D., Lepinski D. (1992): Role of glutatione in repair of free radical damage in hippocampus in vitro. Brain Res. 583, 194-200 http://dx.doi.org/10.1016/S0006-8993(10)80024-1
43. Pulsinelli W. A., Brierley J. B. (1979): A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272 http://dx.doi.org/10.1161/01.STR.10.3.267
44. Reiter R. J., Tan D. X., Manchester L. C., Tamura H. (2007): Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J. Physiol. Pharmacol. (Suppl. 6) 58, 5-22
45. Reiter R. J., Tan D. X., Jou M. J., Korkmaz A., Manchester L. C. Paredes S. D. (2008): Biogenicamines in the reduction of oxidative stress: melatonin and its metabolites. Neuroendocrinol. Lett. 29, 391-398
46. Robertson E. D., English J. D., Sweatt J. D. (1996): A biochemist's view of long-term potentiation. Learn. Mem. 3, 1-24 http://dx.doi.org/10.1101/lm.3.1. 1
47. Saito A., Maier C. M., Narasimhan P., Nishi T., Song Y. S., Yu F., Liu J., Lee Y. S., Nito C., Kamada H., Dodd R. L., Hsieh L. B., Hassid B., Kim E. E., González M., Chan P. H. (2005): Oxidative stress and neuronal death/survival signaling in cerebral ischaemia. Mol. Neurobiol. 31, 105-116 http://dx.doi.org/10.1385/MN:31:1-3:105
48. Sanderson T. H., Reynolds C. A., Kumar R., Przyklenk K., Huttemann M. (2013): Molecular mechanisms of ischemia-reperfusion injury in brain: Pivotal role of the mitochondrial membrane potential in ROS generation. Mol. Neurobiol. 47, 9-23 http://dx.doi.org/10.1007/s12035-012-8344-z
49. Stolc S., Bauer V., Benes L., Tichy M. (1983): Medicine with antiarrhythmic and antihypoxic activity and its method of preparation. Patents: CS 229 067, SWED. 8204693-9, BELG. 894148, SWISS 651 754, BRD P-3231088, SPAIN 553 017, Jap. 151 4040
50. Stolc S., Snirc V., Majekova M., Gasparova Z., Gajdosikova A., Stvrtina S. (2006): Development of the new group of indolederived neuroprotective drugs affecting oxidative stress. Cell. Mol. Neurobiol. 26, 1495-1504 http://dx.doi.org/10.1007/s10571-006-9037-9
51. Stolc S., Povazanec F., Bauer V., Majekova M., Wilcox A. L, Snirc V., Rackova L., Sotnikova R., Stefek M., Gasparova Z., Gajdosikova A., Mihalova D., Alfoldi J. (2010): Pyridoindole derivatives with antioxidant properties; their synthesis and use in therapeutic practice. Slovak Patent No. 287506 (in Slovak)
52. Stolc S., Snirc V., Gajdosikova A., Gajdosik A., Gasparova Z., Ondrejickova O., Sotnikova R., Viola A, Rapta P. (2011): Pyridoindols with antioxidant and neuroprotective actions: A review. In: New Frontiers in Molecular Mechanisms in Neurological and Psychiatric Disorders. (Eds. E. Babusikova, D. Dobrota and J. Lehotsky), Vol. 1, pp. 316-341, Department of Medical Biochemistry, Comenius Universtity in Bratislava, Jessenius Faculty of Medicine in Martin
53. Sugawara T., Chan P. H. (2003): Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antiox. Redox. Signal. 5, 597-607
54. Thiels E., Urban N. N., Gonzales-Burgos G. R., Kanterewitz B. I., Barrionuevo G., Chu C. T., Oury T. D., Klann E. (2000): Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 20, 7631-7639
55. Ujhazy E., Dubovicky M., Ponechalova V., Navarova J., Brucknerova J., Snirc V., Mach M. (2008): Prenatal developmental toxicity study of the pyridolindole antioxidant SMe1EC2 in rats. Neuroendocrinol. Lett. 29, 639-643
56. Vlkolinsky R., Stolc S. (1999): Effect of stobadine, melatonin, and other antioxidants on hypoxia/re-oxygenation-induced synaptic failure in rat hippocampal slices. Brain Res. 850, 118-126 http://dx.doi.org/10.1016/S0006- 8993(99)02110-1
57. Wang H. L., Chen X. T., Yin S. T., Liu J., Tang M. L., Wu C. Y., Ruan D. Y. (2008): Opposite effects of α-lipoic acid on antioxidation and long-term potentiation in control and chronically lead-exposed rats. Naunyn. Schmied. Arch. Pharmacol. 378, 303-310 http://dx.doi.org/10.1007/s00210-008- 0307-6
58. Zhang Y. B., Kan M. Y., Yang Z. H., Ding W. L., Yi J., Chen H. Z., Lu Y. (2009): Neuroprotective effect of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Res. 1287, 146-156 http://dx.doi.org/10. 1016/j.brainres.2009.06.070
59. Zhu L., Fratiglioni L., Guo Z., Aguero-Torres H., Winblad B., Viitanen M. (1998): Association of stroke with dementia, cognitive impairment, and functional disability in the very old. A population-based study. Stroke 29, 2094-2099 http://dx.doi.org/10.1161/01.STR.29.10.2094